NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $438,117 | -90.8% | 27,128 | -76.5% | 0.00% | -90.0% |
| Q2 2023 | $4,781,879 | -37.8% | 115,226 | -9.8% | 0.03% | -36.2% |
| Q1 2023 | $7,682,524 | -22.8% | 127,744 | -5.9% | 0.05% | -13.0% |
| Q4 2022 | $9,956,749 | -21.3% | 135,743 | -18.5% | 0.05% | -15.6% |
| Q3 2022 | $12,651,000 | +20.2% | 166,502 | +9.9% | 0.06% | +42.2% |
| Q2 2022 | $10,527,000 | -6.8% | 151,470 | +11.1% | 0.04% | -2.2% |
| Q1 2022 | $11,291,000 | +51.3% | 136,280 | +37.1% | 0.05% | +7.0% |
| Q4 2021 | $7,463,000 | -33.2% | 99,401 | +3.4% | 0.04% | -29.5% |
| Q3 2021 | $11,165,000 | -47.9% | 96,106 | -0.6% | 0.06% | -55.8% |
| Q2 2021 | $21,437,000 | – | 96,642 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |